SC 13G/A: Kiniksa Pharmaceuticals, Ltd.
Ticker: KNSA · Form: SC 13G/A · Filed: 2024-04-05T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Kiniksa Pharmaceuticals, Ltd..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0001086364-24-007379 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-007379 Filing Date 2024-04-05 Accepted 2024-04-05 12:21:57 Documents 1 Document Format Files Seq Description Document Type Size 1 bmg5269c1010_040424.txt SC 13G/A 11805 Complete submission text file 0001086364-24-007379.txt 13639 Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance) Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100 Kiniksa Pharmaceuticals, Ltd. (Subject) CIK : 0001730430 (see all company filings) EIN. : 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-90491 | Film No.: 24825618 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)